CLABD Stock Price, News & Analysis

CLABD

Company Description

CLABD (OTC: CLABD) is a publicly traded company.

This page provides a comprehensive overview of CLABD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

Latest News

View All

January 21, 2022

—

Core One Labs Announces Successful Proof of Concept and Files Patent for Protection of its Recombinant Production System for Optimized Biosynthesis of Psilocybin

January 18, 2022

—

Core One Labs Special Investor Webcast Rescheduled to Friday, January 21, 2022

January 16, 2022

—

Core One Labs to Host Special Investor Webcast on Tuesday, January 18, 2022

conferences

January 8, 2022

—

Core One Labs Now Also Working to Biosynthesize DMT and Receives License

January 6, 2022

—

Core One Labs Applauds Health Canada’s Amendments to Special Access Program, Allowing Physicians to Request Patient Access to Psychedelic Treatments

December 23, 2021

—

Core One Labs Acquires New Path Laboratories

acquisition

CLABD has 10 recent news articles. Key topics include conferences, acquisition, clinical trial. View all CLABD news →

SEC Filings

View All

No SEC filings available for CLABD.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months